MedTrace Logo

BPH Global Registry

NCT05543200 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 7500

Last updated 2026-04-24

No results posted yet for this study

Summary

Benign prostatic hyperplasia (BPH) is one of the most common performed surgical procedures in urology. Over the past few decades there have been an increasing development of newer surgical treatment options. Additionally, the outcome parameters for BPH treatments have been standardized. While data are available for the initial pivotal studies, post-market release data are lacking. Under the umbrella of uCARE, we have started a prospective, ongoing international registry for recording demographics and outcomes for patients undergoing surgical treatments for BPH.

Conditions

  • Benign Prostatic Hyperplasia
  • Lower Urinary Tract Symptoms

Sponsors & Collaborators

  • Société Internationale d'Urologie

    lead OTHER

Principal Investigators

  • Mihir Desai, MD · University of Southern California

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-03-13
Primary Completion
2026-12-31
Completion
2027-03-31

Countries

  • United States
  • Canada
  • Chile
  • China
  • Cyprus
  • Hong Kong
  • Iran
  • Iraq
  • Italy
  • Lebanon
  • Malaysia
  • Mali
  • Mexico
  • Nigeria
  • Pakistan
  • Qatar
  • South Korea
  • Turkey (Türkiye)
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05543200 on ClinicalTrials.gov